Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial.

PLoS One · 2018 · PMC6028081 · PMID 29965967

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although there was considerable inter-subject variability in the antibody response on Day 28, there was a clear trend of increased anti-J8 IgG antibody levels among participants who were administered the MJ8VAX dose (1.82–9.27 μg/mL).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.